Phase-1/-2 study of pomalidomide in chronic GvHD

Bone Marrow Transplant. 2016 Apr;51(4):612-4. doi: 10.1038/bmt.2015.298. Epub 2015 Dec 14.

Authors

I Pusic¹, M P Rettig¹, J F DiPersio¹, S Bauer¹, K McFarland¹, R P Gale², S Z Pavletic³

Affiliations

¹ Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
² Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK.
³ Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

No abstract available

Publication types

Clinical Trial, Phase I
Clinical Trial, Phase II
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Chronic Disease
Female
Graft vs Host Disease / drug therapy*
Humans
Male
Middle Aged
Pilot Projects
Thalidomide / administration & dosage
Thalidomide / adverse effects
Thalidomide / analogs & derivatives*

Substances

Thalidomide
pomalidomide

Grants and funding

ZIA BC011743/ImNIH/Intramural NIH HHS/United States